Protein Biomarkers

With some therapeutics proving ineffective in as many of 75% of patients, the need for precision medicine is clear, as is the benefit of using selection biomarkers in the drug development process where success rates can triple. With the era of personalized and precision medicine, we have expanded our portfolio beyond the routine safety and efficacy parameters in order to deliver value. We are committed to providing a full repertoire of next-generation assays.

Cerba Research can provide either targeted approaches or broad immune profiling and multifactorial biomarker approaches to identify one or a variety of biomarkers, depending on the stage of your clinical trial and the purpose of the biomarker:

• Guide dose selection
• Characterize mode of action
• Stratify patients
• Predict drug response
• Aid in the prognosis of patients
• Monitor disease